Florida SB 736: Prohibited Conduct Between Authority Figures and Students

Bill Text

736 
Medicaid Coverage of Blood Pressure Monitoring Devices 
2025-12-03T08:20:45Z 
Defining the terms “blood pressure cuff” and “validated at-home blood pressure monitor”; requiring the Agency for Health Care Administration, subject to the availability of funds and certain limitations and directions, to provide coverage for validated at-home blood pressure monitors and blood pressure cuffs for certain Medicaid recipients; providing construction; providing requirements for Medicaid recipients to continue receiving coverage for their validated at-home blood pressure monitors and blood pressure cuffs, etc. 
Original Filed Version 
2026 
S 
2026-10-01T00:00:00Z 
GB 
General Bill 
__ 

 Florida Senate - 2026 SB 736 

 By Senator Burgess 

 23-00686A-26 2026736__ 
 1 A bill to be entitled 
 2 An act relating to Medicaid coverage of blood pressure 
 3 monitoring devices; creating s. 409.9064, F.S.; 
 4 defining the terms “blood pressure cuff” and 
 5 “validated at-home blood pressure monitor”; requiring 
 6 the Agency for Health Care Administration, subject to 
 7 the availability of funds and certain limitations and 
 8 directions, to provide coverage for validated at-home 
 9 blood pressure monitors and blood pressure cuffs for 
 10 certain Medicaid recipients; providing construction; 
 11 providing requirements for Medicaid recipients to 
 12 continue receiving coverage for their validated at 
 13 home blood pressure monitors and blood pressure cuffs; 
 14 requiring the agency to seek federal approval for 
 15 implementation of the act, if needed; requiring the 
 16 agency to include the rate impact of the act in 
 17 certain rates that become effective on a specified 
 18 date; providing an effective date. 
 19 
 20 Be It Enacted by the Legislature of the State of Florida: 
 21 
 22 Section 1. Section 409.9064, Florida Statutes, is created 
 23 to read: 
 24 409.9064 Coverage of blood pressure monitoring devices for 
 25 Medicaid recipients.— 
 26 (1) As used in this section, the term: 
 27 (a) “Blood pressure cuff” means a blood pressure 
 28 measurement accessory that is used with a validated at-home 
 29 blood pressure monitor to measure blood pressure levels and that 
 30 is obtained independently of a validated at-home blood pressure 
 31 monitor in order to ensure proper size and fit for the patient. 
 32 (b) “Validated at-home blood pressure monitor” means a 
 33 blood pressure measurement device that has been validated for 
 34 accuracy and is listed in the United States Blood Pressure 
 35 Validated Device Listing developed by the American Medical 
 36 Association and is designed for the purpose of aiding in the 
 37 treatment of hypertension by measuring blood pressure levels 
 38 outside of the clinical setting. 
 39 (2) Subject to the availability of funds and subject to any 
 40 limitations or directions provided in the General Appropriations 
 41 Act, the agency must provide coverage for validated at-home 
 42 blood pressure monitors and blood pressure cuffs under the 
 43 Medicaid pharmacy benefit for the treatment of a Medicaid 
 44 recipient if: 
 45 (a) The recipient has been diagnosed by his or her primary 
 46 care physician, or another licensed health care practitioner 
 47 authorized to make such diagnosis, with hypertension; and 
 48 (b) A health care practitioner with the applicable 
 49 prescribing authority has prescribed a validated at-home blood 
 50 pressure monitor to assist the recipient and practitioner in 
 51 managing the recipient’s condition. 
 52 (3) Coverage under this section includes the cost of any 
 53 necessary repairs or replacement parts for validated at-home 
 54 blood pressure monitors and blood pressure cuffs. 
 55 (4) To qualify for continued coverage under this section, 
 56 the Medicaid recipient must participate in follow-up care with 
 57 his or her treating health care practitioner, in person or 
 58 through telehealth, at least once every 6 months during the 
 59 first 18 months after the recipient’s first prescription for the 
 60 validated at-home blood pressure monitor has been issued under 
 61 this section, to assess the efficacy of using the monitor for 
 62 treatment or management of his or her hypertension. After the 
 63 first 18 months, such follow-up care must occur at least once 
 64 every 12 months. 
 65 (5) The agency shall seek federal approval, if needed, for 
 66 the implementation of this section. 
 67 Section 2. The Agency for Health Care Administration shall 
 68 include the rate impact of this act in the Medicaid managed 
 69 medical assistance program and long-term care managed care 
 70 program rates, as applicable, which take effect on October 1, 
 71 2026. 
 72 Section 3. This act shall take effect October 1, 2026.